title: Impulsive Aggression as a Comorbidity of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.
abstract: OBJECTIVE
  This article examines the characteristics of impulsive aggression (IA) as a comorbidity in children and adolescents with attention-deficit/hyperactivity disorder (ADHD), focusing on its incidence, impact on ADHD outcomes, need for timely intervention, and limitations of current treatment practices.
  
  
  METHODS
  Relevant literature was retrieved with electronic searches in PubMed and PsycINFO using the search strategy of "ADHD OR attention deficit hyperactivity disorder" AND "impulsive aggression OR reactive aggression OR hostile aggression OR overt aggression" AND "pediatric OR childhood OR children OR pre-adolescent OR adolescent" with separate searches using review OR clinical trial as search limits. Key articles published before the 2007 Expert Consensus Report on IA were identified using citation analysis.
  
  
  RESULTS
  More than 50% of preadolescents with ADHD combined subtype reportedly display clinically significant aggression, with impulsive aggression being the predominant subtype. Impulsive aggression is strongly predictive of a highly unfavorable developmental trajectory characterized by the potential for persistent ADHD, increasing psychosocial burden, accumulating comorbidities, serious lifelong functional deficits across a broad range of domains, delinquency/criminality, and adult antisocial behavior. Impulsive aggression, which triggers peer rejection and a vicious cycle of escalating dysfunction, may be a key factor in unfavorable psychosocial outcomes attributed to ADHD. Because severe aggressive behavior does not remit in many children when treated with primary ADHD therapy (i.e., stimulants and behavioral therapy), a common practice is to add medication of a different class to specifically target aggressive behavior.
  
  
  CONCLUSIONS
  Impulsive aggression in children and adolescents with ADHD is a serious clinical and public health problem. Although adjunctive therapy with an aggression-targeted agent is widely recommended when aggressive behaviors do not remit with primary ADHD therapy, empirical evidence does not currently support the use of any specific agent. Randomized controlled trials are needed to identify aggression-targeted agents with favorable benefit-risk profiles.
authors.affiliation: 1 NeuroScience, Inc. , Herndon, Virginia.
authors.forename: Keith E
authors.initials: KE
authors.lastname: Saylor
authors.affiliation: 2 Behavioral Medical Center , Troy, Michigan.
authors.forename: Birgit H
authors.initials: BH
authors.lastname: Amann
mesh_terms: D000293:Adolescent; D000294:Adolescent Behavior / Q000523:psychology; D000374:Aggression; D001289:Attention Deficit Disorder with Hyperactivity / Q000523:psychology* / Q000628:therapy; D002648:Child; D002652:Child Behavior / Q000523:psychology; D015897:Comorbidity; D006801:Humans; D007175:Impulsive Behavior